International Stem Cell amends Optimus private placement of preferreds

By Devika Patel

Knoxville, Tenn., Oct. 19 - International Stem Cell Corp. modified a private placement of its series E preferred stock on Oct. 14, according to an 8-K filed Monday with the Securities and Exchange Commission. The company raised $500,000 in the first tranche on Oct. 14.

The preferreds will be sold to Optimus Capital Partners, LLC. Optimus also will receive warrants for 1,932,121 common shares, which are exercisable at $0.67.

International Stem Cell has headquarters in Oceanside, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.